StockData
Nephros Inc logo

Nephros Inc (NEPH) stock

NEPHNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 13/3023% below fair value
$2.90−0.10 (-3.33%)

Close on Nov 17, 2026Market cap $31.49MP/E 18.1Yield –

Nephros revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Nephros's revenue for the twelve months ending Jun 30, 2026 was $20.72M, up 24.2% year over year. For fiscal 2025 it was $18.79M, up 32.7% from the year before. Over ten years it grew 25.5% a year on average. The highest annual figure on record is $18.79M in fiscal 2025.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$18.79M+32.7%
FY2024Dec 31, 2024$14.16M-0.5%
FY2023Dec 31, 2023$14.24M+42.7%
FY2022Dec 31, 2022$9.98M-2.4%
FY2021Dec 31, 2021$10.22M+19.3%
FY2020Dec 31, 2020$8.56M-17.2%
FY2019Dec 31, 2019$10.33M+81.7%
FY2018Dec 31, 2018$5.69M+49.3%
FY2017Dec 31, 2017$3.81M+64.2%
FY2016Dec 31, 2016$2.32M+19.3%
FY2015Dec 31, 2015$1.94M+11.2%
FY2014Dec 31, 2014$1.75M+0.5%
FY2013Dec 31, 2013$1.74M-3.7%
FY2012Dec 31, 2012$1.81M-18.4%
FY2011Dec 31, 2011$2.21M-24.6%
FY2010Dec 31, 2010$2.94M–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$6.02M+36.2%
Q1 FY2026Mar 31, 2026$5.21M+6.9%
Q4 FY2025Dec 31, 2025$4.73M+22.2%
Q3 FY2025Sep 30, 2025$4.76M+35.4%
Q2 FY2025Jun 30, 2025$4.42M+35.9%
Q1 FY2025Mar 31, 2025$4.88M+38.5%
Q4 FY2024Dec 31, 2024$3.87M+18.9%
Q3 FY2024Sep 30, 2024$3.52M-6.0%
Q2 FY2024Jun 30, 2024$3.25M-8.3%
Q1 FY2024Mar 31, 2024$3.52M-4.7%
Q4 FY2023Dec 31, 2023$3.25M+27.2%
Q3 FY2023Sep 30, 2023$3.74M+55.3%
Q2 FY2023Jun 30, 2023$3.55M+24.4%
Q1 FY2023Mar 31, 2023$3.70M+71.2%
Q4 FY2022Dec 31, 2022$2.56M-5.7%
Q3 FY2022Sep 30, 2022$2.41M-6.6%
Q2 FY2022Jun 30, 2022$2.85M+25.8%
Q1 FY2022Mar 31, 2022$2.16M-21.1%
Q4 FY2021Dec 31, 2021$2.71M+16.2%
Q3 FY2021Sep 30, 2021$2.58M+21.5%
Q2 FY2021Jun 30, 2021$2.27M+43.7%
Q1 FY2021Mar 31, 2021$2.74M+8.2%
Q4 FY2020Dec 31, 2020$2.33M-26.2%
Q3 FY2020Sep 30, 2020$2.12M-31.5%
Q2 FY2020Jun 30, 2020$1.58M-31.7%
Q1 FY2020Mar 31, 2020$2.53M+43.0%
Q4 FY2019Dec 31, 2019$3.16M+96.1%
Q3 FY2019Sep 30, 2019$3.10M+79.5%
Q2 FY2019Jun 30, 2019$2.31M+69.0%
Q1 FY2019Mar 31, 2019$1.77M+79.6%
Q4 FY2018Dec 31, 2018$1.61M+24.0%
Q3 FY2018Sep 30, 2018$1.72M+88.2%
Q2 FY2018Jun 30, 2018$1.37M+59.0%
Q1 FY2018Mar 31, 2018$985.00K+34.2%
Q4 FY2017Dec 31, 2017$1.30M+74.5%
Q3 FY2017Sep 30, 2017$916.00K+92.8%
Q2 FY2017Jun 30, 2017$859.00K–
Q1 FY2017Mar 31, 2017$734.00K–
Q4 FY2016Dec 31, 2016$745.00K–
Q3 FY2016Sep 30, 2016$475.00K–

More Nephros figures

See a number that looks wrong?